• Home >
  • Research & Development

Pipeline

Our clinical development program focuses on applications of our lead product candidate, taurolidine.

Catheter Lock Solutions

HEMODIALYSIS (TAUROLIDINE + HEPARIN)

Pre-Clinical

Phase 1

Phase 2

Phase 3

Registration

Approved

ONCOLOGY (TAUROLIDINE + HEPARIN)

Pre-Clinical

Phase 1

Phase 2

Phase 3

Registration

Approved

PEDIATRIC HEMODIALYSIS (TAUROLIDINE + HEPARIN)

Pre-Clinical

Phase 1

Phase 2

Phase 3

Registration

Approved

TOTAL PARENTERAL NUTRITION (TAUROLIDINE + HEPARIN)

Pre-Clinical

Phase 1

Phase 2

Phase 3

Registration

Approved

Therapeutic Uses

ONCOLOGY - NEUROBLASTOMA

Pre-Clinical

Phase 1

Phase 2

Phase 3

Registration

Approved

Early science

See an overview of our product candidates

Learn more